bioERGOtech is a foundation advancing Engineered Living Systems — transforming living cells into precisely controllable therapeutic agents through the convergence of synthetic biology, AI, and automated biomanufacturing.
bioERGOtech is a foundation dedicated to bridging the critical gap between biotech's promises and tangible medical breakthroughs. We develop pioneering research projects that advance Engineered Living Systems — turning cells into predictable, manufacturable, and controllable living medicines.
At its core, bioERGOtech transforms how biological research is conducted by developing “digital scientists” — AI-powered systems that make experiments smarter, not just faster, across our four integrated scientific pillars.
The foundation initiates and nurtures new research projects spanning digital twin therapeutics, synthetic biology and cell engineering, automated biomanufacturing, and integrated multi-omics analytics — all focused on translating scientific potential into real patient impact.
We believe in a pragmatic, focused approach that delivers real impact for patients suffering from chronic diseases.
Our approach combines cutting-edge AI technology with traditional scientific methods to create a more efficient research ecosystem.
Instead of randomly exploring possibilities, our systems analyze data in real-time to determine the most promising pathways for further investigation.
We focus on building solutions that address specific research markets.
We prioritize projects with speedy iteration times of less than a year from idea to implementation.
We target immediate human needs with practical solutions, focusing on day-to-day challenges that make a tangible difference for patients today.
We identify core challenges in laboratory research for chronic diseases and develop targeted solutions that address fundamental issues rather than symptoms.
We create sophisticated algorithms that optimize experiments and research processes for maximum efficiency and breakthrough potential.
We enable other research organizations to adopt and integrate our systems, transforming how chronic disease research is conducted worldwide.
Our foundation is guided by principles that foster meaningful collaboration and sustainable advancement across the global research landscape.
Our strategy centres on building dedicated, interdisciplinary teams that collaborate closely with partners worldwide. Through the development of foundational technologies applicable across therapeutic domains, we aspire to create an environment where progress in one scientific area naturally enriches neighbouring fields.
We embrace emerging technologies and reimagine research processes from the ground up.
When projects demonstrate viability, we support their growth into independent ventures with fair recognition for their creators.
We value lean, empowered teams supported by intelligent automation, allowing us to respond swiftly to evolving scientific needs.
We advance four integrated scientific pillars to transform living cells into precisely controllable therapeutic agents.
Patient-specific computational models that predict therapeutic outcomes and enable real-time treatment optimization.
Design and construction of programmable cellular systems with precise control over therapeutic function, safety, and persistence.
Fully integrated robotic platforms that manufacture cell therapies with minimal human intervention and AI-driven process optimization.
Comprehensive molecular profiling throughout manufacturing and treatment to predict product quality and patient response.
We are building a network of innovation hubs across Europe and the Middle East.
Our founding innovation hub in Southern Italy, developing and testing our core technologies at the intersection of biotech and industrial heritage.
Our Swiss hub, embedded in one of Europe's leading life sciences and technology ecosystems.
Our Middle Eastern hub, contributing to the region's growing commitment to healthcare innovation and knowledge-based economic development.
The Italian startup targets the non-human market first before expanding into clinical genomics.
Know More →
A Conversation with Guido Putignano on Navigating Academia and Entrepreneurship.
Know More →
The Bridge Between Research and Real-World Impact.
Know More →
A recap of our successful launch event for the Taranto Biotech Hub.
Know More →
How a young scientist explores connections between traditional medicine and modern technology.
Know More →
Innovation in the sector.
Know More →